# Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery

> **NCT06990100** · NA · COMPLETED · sponsor: **SACIMEX** · enrollment: 36 (actual)

## Conditions studied

- ACL Rupture

## Interventions

- **DEVICE:** ACL surgery

## Key facts

- **NCT ID:** NCT06990100
- **Lead sponsor:** SACIMEX
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-05-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990100, "Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06990100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*